Viewing Study NCT02474004


Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2026-01-10 @ 7:39 AM
Study NCT ID: NCT02474004
Status: UNKNOWN
Last Update Posted: 2016-07-19
First Post: 2015-06-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Gait Analysis Meniscal Repair
Sponsor: Michael Liebensteiner
Organization:

Study Overview

Official Title: 3D-gait Analysis in Patients With Medial Meniscus Repair vs. Partial Meniscectomy
Status: UNKNOWN
Status Verified Date: 2016-07
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: In the past it was shown, that medial partial meniscectomy (MPM) leads to an increase of the knee adduction moment (KAM) during walking. Other researches found out that an increase of the KAM is an important factor contributing to degeneration joint disease of the knee (osteoarthritis). Today, medial menicus repair (MMR) is favoured by many knee surgeons, because preserving as much of the meniscus as possible is assumed to delay degenerative joint disease.

The investigators hypothesize significant differences in knee adduction moments between patients treated with partial medial meniscectomy vs. patients treated with medial meniscus repair (hypothesis 1; major hypothesis). Additionally, it is hypothesized that: the mentioned groups differ with respect to other kinetic and kinematic key parameters of gait (hypothesis 2) and that the knee adduction moment correlates with the clinical outcome as determined by a typical knee score (hypothesis 3).
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: